A mannose-binding blood protein reduces the risk of infections drug treatment with cytostatic agents
Nilsson, A.; Björk, O.
Lakartidningen 98(50): 5780
2001
ISSN/ISBN: 0023-7205 PMID: 11789102 Document Number: 527952
Document emailed within 1 workday
Related Documents
Lumholtz, I.B. 1977: Drug information: agents in the treatment of neoplastic diseases. Therapeutic main group: cytostatic agents. 1 Sygeplejersken 77(16): 13Mann, K.K.; André, S.; Gabius, H.J.; Sharp, J.G. 1994: Phenotype-associated lectin-binding profiles of normal and transformed blood cells: a comparative analysis of mannose- and galactose-binding lectins from plants and human serum/placenta European Journal of Cell Biology 65(1): 145-151
Hawke, C. 1997: Screening for mannose binding protein gene in routine practice is unnecessary Bmj 315(7105): 428-429
Bellamy, R.; Ruwende, C.; McAdam, K.P.; Thursz, M.; Sumiya, M.; Summerfield, J.; Gilbert, S.C.; Corrah, T.; Kwiatkowski, D.; Whittle, H.C.; Hill, A.V. 1998: Mannose binding protein deficiency is not associated with malaria, hepatitis B carriage nor tuberculosis in Africans Qjm: Monthly Journal of the Association of Physicians 91(1): 13-18
Gong, R.; Liu, Z.; Chen, Z.; Li, L. 2002: Genetic variation of mannose-binding protein associated with glomerular immune deposition in IgA nephropathy Chinese Medical Journal 115(2): 192-196
Koch, A.; Melbye, M.; Sørensen, P.; Homøe, P.; Madsen, H.O.; Mølbak, K.år.; Hansen, C.H.; Andersen, L.H.øg.; Hahn, G.W.; Garred, P. 2002: Acute respiratory tract infections and mannose-binding lectin insufficiency in small children Ugeskrift for Laeger 164(48): 5635-5640
Lumholtz, I.B. 1979: Drug information: agents for the treatment of virus infections. Idoxuridine (Iduridin) Sygeplejersken 79(22): 25
Wisløff, F.; Brinch, L.; Bruserud, O.; Dahl, I.M.; Lamvik, J. 1994: Treatment with high-dose cytostatic agents Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 114(26): 3115-3116
Rauh, J.; Pluntke, S.; Müller, C. 2004: Treatment of perivascular extravasation of cytostatic agents MMW Fortschritte der Medizin 146(31-32): 23-24; 26-27
Steineck, G.; Wijkström, H.; Borghede, G. 1994: Treatment of bladder cancer with cytostatic agents Lakartidningen 91(5): 397-404
Halvorsen, S. 1971: Cytostatic agents in treatment of the nephrotic syndrome Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 91(10): 737
Chlund, K. 1970: Treatment of ulcerative colitis with cytostatic agents Wiener Medizinische Wochenschrift 120(16): 274
Stepanenko, O.'g.V.; Povarova, O.I.; Fonin, A.V.; Stepanenko, O.V. 2010: Stability of sugar-binding proteins: D-galactose/D-glucose-binding protein from Escherichia coli and trehalose/maltose-binding protein from Thermococcus litoralis Tsitologiia 52(11): 950-954
Chicault, M.; Luu-Duc, C.; Boucherle, A. 1990: Drug-protein interactions. Comparative studies of levamisole and structural analogs or agents with immunomodulatory effect on the mechanism of protein aggregation Arzneimittel-Forschung 40(1): 55-57
Ringborg, U. 1990: Identification of resistance factors is a step towards optimized treatment with cytostatic agents Lakartidningen 87(21): 1880-1882
Soothill, J.F. 2002: Mannose-binding lectin Lancet 359(9300): 82
Larsson, P.A. 1999: Treatment with cytostatic agents should be considered in colorectal cancer. it improves prognosis and quality of life Lakartidningen 96(19): 2314-2316
Dubois, N.; Muller, N.; Lapicque, F.; Gillet, P.; Netter, P.; Royer, R.J. 1993: Stereoselective protein binding of non-steroidal anti-inflammatory agents. Pharmacological implications Therapie 48(4): 335-339
Kojima, M.; Presanis, J.S.; Sim, R.B. 2003: The mannose-binding lectin (MBL) route for activation of complement Advances in Experimental Medicine and Biology 535: 229-250
Svennevig, J.L.; Wennberg, J.E.; Bernstein, O.; Lange, J. 1975: Cytostatic drug combinations in the treatment of metastatic cancer of the breast Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 95(32): 1854-1855; 1866